Measuring childhood cancer late effects:evidence of a healthy survivor effect

INTRODUCTION: Given considerable focus on health outcomes among childhood cancer survivors, we aimed to explore whether survivor bias is apparent during long-term follow-up of childhood cancer survivors. METHODS: We identified all 1-year survivors of cancer diagnosed before 20 years of age in Denmar...

Full description

Bibliographic Details
Published in:European Journal of Epidemiology
Main Authors: Asdahl, Peter Haubjerg, Ojha, Rohit Priyadarshi, Winther, Jeanette Falck, Holmqvist, Anna Sällfors, de Fine Licht, Sofie, Gudmundsdottir, Thorgerdur, Madanat-Harjuoja, Laura, Tryggvadottir, Laufey, Andersen, Klaus Kaae, Hasle, Henrik
Format: Article in Journal/Newspaper
Language:English
Published: 2017
Subjects:
Online Access:https://pure.au.dk/portal/en/publications/214a2b9c-d400-435d-8ee1-9bcfd109ad7e
https://doi.org/10.1007/s10654-017-0305-4
Description
Summary:INTRODUCTION: Given considerable focus on health outcomes among childhood cancer survivors, we aimed to explore whether survivor bias is apparent during long-term follow-up of childhood cancer survivors. METHODS: We identified all 1-year survivors of cancer diagnosed before 20 years of age in Denmark, Finland, Iceland, and Sweden. From the general population, we randomly sampled a comparison cohort. Study individuals were followed for hospitalizations for diseases of the gastroenterological tract, endocrine system, cardiovascular system, or urinary tract from the start of the cancer registries to 2010. We estimated cumulative incidence with death as competing risk and used threshold regression to compare the hazards of the diseases of interest at ages 20, 40, 60, and 75 years. RESULTS: Our study included 27,007 one-year survivors of childhood cancer and 165,620 individuals from the general population. The cumulative incidence of all four outcomes was higher for childhood cancer survivors during early adulthood, but for three outcomes, the cumulative incidence was higher for the general population after age 55 years. The hazard ratios (HRs) decreased for all outcomes with increasing age, and for two of the outcomes, the hazards were higher for the general population at older ages (endocrine diseases: age-specific HRs = 3.0, 1.4, 1.0, 0.87; Cardiovascular diseases: age-specific HRs = 4.1, 1.4, 0.97, 0.84). CONCLUSIONS: Our findings provide empirical evidence that survivor bias attenuates measures of association when comparing survivors with the general population. The design and analysis of studies among childhood cancer survivors, particularly as this population attains older ages, should account for survivor bias to avoid misinterpreting estimates of disease burden.